Sign In
Buy GPCR
$48.04
-1.43 (-2.89%)
At Close: Jul 31, 2026
Buying Shares of These 2 Biotech Stocks Could Be a Brilliant Move in 5 Years
10:15am, Monday, 12'th Jun 2023
Novo Nordisk's medicines for obesity and diabetes are spawning many copycats. Viking Therapeutics' stock is soaring thanks to its favorable early results.
Structure Therapeutics to Present at Jefferies Healthcare Conference
04:30pm, Wednesday, 31'st May 2023
SAN FRANCISCO and SHANGHAI, May 31, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeu
Structure Therapeutics: Developing Innovative Treatments For Metabolic And Fibrotic Diseases
04:31pm, Wednesday, 12'th Apr 2023
Structure Therapeutics has a promising pipeline of product candidates, including GSBR-1290, a GLP-1R agonist for diabetes and obesity, and APJR and LPA1R agonists and antagonists for various indicatio
There's a Lot to Love About Mineralys' Valentine's Day IPO
09:23am, Monday, 13'th Feb 2023
It has been less than a year since Mineralys Therapeutics (NASDAQ: MLYS) listed its IPO, but the activity has been quite hot, particularly since the top of the year. With 2.71 million in trading volum
Drug Maker Structure Therapeutics Offers Big Bet on ‘Diabesity' With IPO
10:46pm, Thursday, 02'nd Feb 2023
This article was produced and syndicated by Wealth of Geeks.
Structure Therapeutics Hopes To Wow Investors With Cutting-Edge Drug Tech
10:25am, Thursday, 02'nd Feb 2023
Structure Therapeutics could raise up to $135 million in its IPO set to make its trading debut this week. The company is hoping to impress investors with its cutting-edge drugs, strong executive team
Structure Therapeutics sets IPO terms, to be valued at up to $522 million
06:45am, Monday, 30'th Jan 2023
Structure Therapeutics Inc. has set terms for its initial public offering (IPO), as the California-based biopharmaceutical company developing oral therapeutics looks to raise up to $134.25 million. Th
Structure Therapeutics Starts U.S. IPO Plan
01:09pm, Tuesday, 17'th Jan 2023
Structure Therapeutics has filed to raise $119 million in a U.S. IPO, although the final figure may differ. The firm is developing treatments for Type 2 diabetes and other serious medical conditions.
